Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: Assessment of matrix effects and assay performance

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 8, 2010, Pages 583-591

  Vethe, Nils T ^a   Gjerdalen, Laila C ^a   Bergan, Stein ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Cyclosporine; Everolimus; Immunosuppressants; LC MS MS; Mass spectrometry; Matrix effects; Sirolimus; Tacrolimus

Indexed keywords

ASCOMYCIN; CYCLOSPORIN; EVEROLIMUS; GLYCEROPHOSPHORYLCHOLINE; RAPAMYCIN; TACROLIMUS;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; CYCLOSPORINE; HUMANS; REFERENCE STANDARDS; SIROLIMUS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 78649289855     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.531141     Document Type: Article

References (18)

1. Korecka M, Shaw LM. Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice. Ann Transplant 2009;14:61-72.
2. Annesley TM, Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin Chem 2004;50:1845-8.
3. Ansermot N, Fathi M, Veuthey JL, Desmeules J, Rudaz S, Hochstrasser D. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem 2008;41:728-35.
4. Bogusz MJ, Enazi EA, Hassan H, bdel-Jawaad J, Ruwaily JA, Tufail MA. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2007;850:471-80.
5. Keevil BG, McCann SJ, Cooper DP, Morris MR. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 2002;39:487-92.
6. Koster RA, Dijkers EC, Uges DR. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 2009;31:116-25.
7. Meinitzer A, Gartner G, Pilz S, Stettin M. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus. Ther Drug Monit 2010;32:61-6.
8. Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine. Ther Drug Monit 2005;27:144-50.
9. Salm P, Taylor PJ, Rooney F. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood. Ther Drug Monit 2008;30:292-300.
10. Seger C, Tentschert K, Stoggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 2009;4:526-34.
11. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem 2002;48:955-8.
12. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019-30.
13. Srinivas NR. Dodging matrix effects in liquid chromatography tandem mass spectrometric assays - compilation of key learnings and perspectives. Biomed Chromatogr 2009;23:451-4.
14. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospraytandem mass spectrometry. Clin Biochem 2005;38:328-34.
15. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2198-207.
16. Bouzas L, Tutor JC. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay. Clin Biochem 2007;40:132-6.
17. Pieri M, Miraglia N, Gentile A, Polichetti G, Castiglia L, Federico S, Sabbatini M, Basile V, Tarantino G, Acampora A, Capone D. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation. Int J Immunopathol Pharmacol 2008;21:585-94.
18. Little JL, Wempe MF, Buchanan CM. Liquid chromatographymass spectrometry/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2006;833:219-30.